Search

everythinglearnresearchcommunity

for

Search:↓

Early treatment with certain drug combinations improved COVID-19 outcomes and prevented severe disease in males, including those at higher risk.

Men with male pattern baldness had worse COVID-19 symptoms, but early treatment with certain drugs improved outcomes for all.

Using Favipiravir, a COVID-19 treatment drug, likely doesn't cause hair loss.

Immune cells in Hidradenitis suppurativa become more inflammatory and may be important for treatment targets.

Baicalin may help reduce excessive male hormone levels in PCOS.

Deferasirox combined with sorafenib reduces liver cancer risk and lessens treatment side effects.

Older age, pre-existing skin conditions, cirrhosis, and pegylated interferon use increase the risk of skin issues during hepatitis C treatment.

A patient with a rare disease had a unique genetic mutation linked to their symptoms.

An HIV patient's complete hair loss was reversed after switching from lopinavir/ritonavir to nelfinavir.

COVID-19 can cause temporary hair loss, which is commonly reversible with treatment.

People with hypohidrotic ectodermal dysplasia are more likely to experience long-term fatigue and hair loss after COVID-19.

COVID-19 has widely affected health, various industries, and the economy, but also led to more remote work and less pollution.

Diphenylcyclopropenone (DPCP) effectively treated both alopecia areata and verruca vulgaris.

Follow these guidelines to safely and effectively use energy-based devices in aesthetic treatments.

Nirmatrelvir/Ritonavir treatment may lead to a weaker immune response to COVID-19, but doesn't affect the chance of rebound.

STAR particles can improve the effectiveness of topical hair growth treatments without causing skin irritation.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

COVID-toes show a unique immune response over time, different from vaccine-related chilblains.

Women with diffuse hair loss often have lower iron and vitamin D levels, but their thyroid function is typically normal.

The document's conclusion cannot be provided because the content is not accessible.

Long-haul COVID can cause lasting symptoms affecting many body systems and may be linked to ongoing inflammation and immune system issues.

Acne is linked to complex skin microbe interactions, and new findings suggest microbiome-based treatments could be effective.

Many patients experience long-lasting symptoms like fatigue and pain after COVID-19, regardless of initial disease severity.

Human mitochondrial DNA polymerase makes very few errors, crucial for preventing degenerative diseases.

Damaging mutations in NFKB2 cause a severe and distinct form of primary immunodeficiency with early-onset and often ACTH-deficiency.

Interferon and ribavirin can cause serious skin reactions and other health issues.

The L412F variant of TLR3 is linked to skin infections, more viral infections, and autoimmune issues.

9-cis-retinoic acid showed some effectiveness in treating AIDS-related Kaposi sarcoma but had significant side effects at higher doses.

Loss of OGG1 increases skin inflammation and auto-antibodies in lupus.

Dutasteride treatment in men with mild to moderate COVID-19 reduced viral shedding, inflammation, and recovery time without serious side effects.